University of Veterinary Medicine Vienna - Research portal

Diagrammed Link to Homepage University of Veterinary Medicine, Vienna

Selected Publication:

Open Access Logo

Type of publication: Journal Article
Type of document: Full Paper

Year: 2005

Authors: Wienhold, D; Armengol, E; Marquardt, A; Marquardt, C; Voigt, H; Büttner, M; Saalmüller, A; Pfaff, E

Title: Immunomodulatory effect of plasmids co-expressing cytokines in classical swine fever virus subunit gp55/E2-DNA vaccination.

Source: Vet Res. 2005; 36(4):571-587

Authors Vetmeduni Vienna:

Saalmüller Armin

Vetmed Research Units
Institute of Immunology

The aim of this study was to determine the immunomodulatory effects of IL-12, IL-18 and CD154 (CD40 ligand, CD40L) in DNA-vaccination against the classical swine fever virus. Four recombinant plasmids were constructed including the CSFV coding region for the glycoprotein gp55/E2 alone or together with porcine IL-12, IL-18 or CD154 genes. Five groups of four pigs each were immunized intramuscularly (i.m.) three times with the respective constructs. The control group was inoculated with empty plasmid DNA. Eighteen days after the final immunization, the pigs were challenged with a lethal dose of CSFV strain Eystrup and monitored for a further 16 days. This study showed that co-delivery of IL-18 and CD154 induced an earlier appearance of serum antibodies, reduced B-cell deficiency after infection and protected pigs against a lethal CSFV infection. In contrast, co-delivery of IL-12 led to a reduced titer of neutralizing antibodies and protection against a lethal CSFV challenge in comparison to the other pigs and to pigs that were immunized with a gp55/E2 plasmid alone.

Keywords Pubmed: Adjuvants, Immunologic/genetics*
CD40 Ligand/genetics
CD40 Ligand/immunology
Classical Swine Fever/prevention & control*
Classical swine fever virus/immunology*
Gene Expression
Time Factors
Vaccines, DNA/immunology*
Viral Proteins/immunology
Viral Vaccines/immunology*

© University of Veterinary Medicine ViennaHelp and DownloadsAccessibility statement